| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc4acbdbbb11e513d7c419bd87b9bdd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_902474a26ba632dd12fead50cee4fa7f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2404 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B41-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-02 |
| filingDate |
2020-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_057f7e206237730a3ecea7fba4908285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e68cd7ea483975ce0f27af4bdca45ca1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f11754ba4aa781a885257646816caf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7726aed6f61329301e90071bd768d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15bcec496cc3a8b1b888a85388f0423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04544660bf7804d39b872b44f6714d49 |
| publicationDate |
2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020172506-A1 |
| titleOfInvention |
Methods of making high enantioselective secondary alcohols |
| abstract |
A new process to synthesis of compound OBI-3424 R-form and S-form products is provided. The "R-form" compound OBI-3423 was first synthesized with 48% overall yield from compound OBI-3424-5 by installation of the labile phosphate motif at later stage. The stereo chemistry is established by 5 steps chemo-enzyme combination synthesis to afford 99% optical purity, After then, the "S-form" compound OBI-3424 is prepared with improving overall yield of 54% from compound OBI-3424-5. The stereo chemistry is established by 4 steps combination of chemo-enzyme synthesis with excellent optical purity of 99%. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3821884-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022178821-A1 |
| priorityDate |
2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |